Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure

Bitter T, Westerheide N, Prinz C, Hossain MS, Vogt J, Langer C, Horstkotte D, Oldenburg O (2011)
European Heart Journal 32(1): 61-74.

Download
No fulltext has been uploaded. References only!
Journal Article | Original Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ;
Abstract / Notes
Aims The aim of this first large-scale long-term study was to investigate whether obstructive sleep apnoea (OSA) and/or central sleep apnoea (CSA) are associated with an increased risk of malignant cardiac arrhythmias in patients with congestive heart failure (CHF). Methods and results Of 472 CHF patients who were screened for sleep disordered breathing (SDB) 6 months after implantation of a cardiac resynchronization device with cardioverter-defibrillator, 283 remained untreated [170 with mild or no sleep disordered breathing (mnSDB) and 113 patients declined ventilation therapy] and were included into this study. During follow-up (48 months), data on appropriately monitored ventricular arrhythmias as well as appropriate cardioverter-defibrillator therapies were obtained from 255 of these patients (90.1%). Time period to first monitored ventricular arrhythmias and to first appropriate cardioverter-defibrillator therapy were significantly shorter in patients with either CSA or OSA. Forward stepwise Cox models revealed an independent correlation for CSA and OSA regarding monitored ventricular arrhythmias [apnoea-hypopnoea index (AHI) >= 5 h(-1): CSA HR 2.15, 95% CI 1.40-3.30, P < 0.001; OSA HR 1.69, 95% CI 1.64-1.75, P = 0.001; AHI >= 15 h(-1): CSA HR 2.06, 95% CI 1.40-3.05, P < 0.001; OSA HR 1.69, 95% CI 1.14-2.51, P = 0.02] and appropriate cardioverter-defibrillator therapies (AHI >= 5 h(-1): CSA HR 3.24, 95% CI 1.86-5.64, P < 0.001; OSA HR 2.07, 95% CI 1.14-3.77, P = 0.02; AHI >= 15 h(-1): CSA HR 3.41, 95% CI 2.10-5.54, P < 0.001; OSA HR 2.10, 95% CI 1.17-3.78, P = 0.01). Conclusion In patients with CHF, CSA and OSA are independently associated with an increased risk for ventricular arrhythmias and appropriate cardioverter-defibrillator therapies.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Bitter T, Westerheide N, Prinz C, et al. Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. European Heart Journal. 2011;32(1):61-74.
Bitter, T., Westerheide, N., Prinz, C., Hossain, M. S., Vogt, J., Langer, C., Horstkotte, D., et al. (2011). Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. European Heart Journal, 32(1), 61-74. doi:10.1093/eurheartj/ehq327
Bitter, T., Westerheide, N., Prinz, C., Hossain, M. S., Vogt, J., Langer, C., Horstkotte, D., and Oldenburg, O. (2011). Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. European Heart Journal 32, 61-74.
Bitter, T., et al., 2011. Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. European Heart Journal, 32(1), p 61-74.
T. Bitter, et al., “Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure”, European Heart Journal, vol. 32, 2011, pp. 61-74.
Bitter, T., Westerheide, N., Prinz, C., Hossain, M.S., Vogt, J., Langer, C., Horstkotte, D., Oldenburg, O.: Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. European Heart Journal. 32, 61-74 (2011).
Bitter, Thomas, Westerheide, Nina, Prinz, Christian, Hossain, Mohamed Sajid, Vogt, Juergen, Langer, Christoph, Horstkotte, Dieter, and Oldenburg, Olaf. “Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure”. European Heart Journal 32.1 (2011): 61-74.
This data publication is cited in the following publications:
This publication cites the following data publications:

91 Citations in Europe PMC

Data provided by Europe PubMed Central.

Importance and management of chronic sleep apnoea in cardiology.
Jaffe LM, Kjekshus J, Gottlieb SS., Eur Heart J 34(11), 2013
PMID: 22427382
Transvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failure.
Ponikowski P, Javaheri S, Michalkiewicz D, Bart BA, Czarnecka D, Jastrzebski M, Kusiak A, Augostini R, Jagielski D, Witkowski T, Khayat RN, Oldenburg O, Gutleben KJ, Bitter T, Karim R, Iber C, Hasan A, Hibler K, Germany R, Abraham WT., Eur Heart J 33(7), 2012
PMID: 21856678
Symptoms of sleep apnoea in chronic heart failure--results from a prospective cohort study in 1,500 patients.
Bitter T, Westerheide N, Hossain SM, Prinz C, Horstkotte D, Oldenburg O., Sleep Breath 16(3), 2012
PMID: 21874604
[Sleep disordered breathing and nonsustained ventricular tachycardia in patients with chronic heart failure].
Koehler U, Apelt S, Cassel W, Hildebrandt O, Nell C, Ranft S, Grimm W., Wien Klin Wochenschr 124(3-4), 2012
PMID: 22080939
[Sleep-disordered breathing and cardiac arrhythmias].
Bitter T, Körber B, Horstkotte D, Oldenburg O., Herzschrittmacherther Elektrophysiol 23(1), 2012
PMID: 22351149
The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?
Triposkiadis F, Starling RC, Boudoulas H, Giamouzis G, Butler J., Heart Fail Rev 17(3), 2012
PMID: 22086438
Long-term auto-servoventilation or constant positive pressure in heart failure and coexisting central with obstructive sleep apnea.
Randerath WJ, Nothofer G, Priegnitz C, Anduleit N, Treml M, Kehl V, Galetke W., Chest 142(2), 2012
PMID: 22281801
The contribution of heart failure to sleep disturbances and depressive symptoms in older adults.
Johansson P, Riegel B, Svensson E, Broström A, Alehagen U, Dahlström U, Jaarsma T., J Geriatr Psychiatry Neurol 25(3), 2012
PMID: 23124012
Treatment of obstructive sleep apnea in patients with cardiac arrhythmias.
Sahadevan J, Srinivasan D., Curr Treat Options Cardiovasc Med 14(5), 2012
PMID: 22923098
Sleep apnoea and malignant ventricular arrhythmias in heart failure.
Floras J, Andreas S., Eur Heart J 32(1), 2011
PMID: 20929983
Circadian pattern of life-threatening ventricular arrhythmia in patients with sleep-disordered breathing and implantable cardioverter-defibrillators.
Zeidan-Shwiri T, Aronson D, Atalla K, Blich M, Suleiman M, Marai I, Gepstein L, Lavie L, Lavie P, Boulos M., Heart Rhythm 8(5), 2011
PMID: 21185402
The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care.
McKelvie RS, Moe GW, Cheung A, Costigan J, Ducharme A, Estrella-Holder E, Ezekowitz JA, Floras J, Giannetti N, Grzeslo A, Harkness K, Heckman GA, Howlett JG, Kouz S, Leblanc K, Mann E, O'Meara E, Rajda M, Rao V, Simon J, Swiggum E, Zieroth S, Arnold JM, Ashton T, D'Astous M, Dorian P, Haddad H, Isaac DL, Leblanc MH, Liu P, Sussex B, Ross HJ., Can J Cardiol 27(3), 2011
PMID: 21601772

54 References

Data provided by Europe PubMed Central.

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).
Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines (CPG), Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Tendera M, Auricchio A, Bax J, Bohm M, Corra U, della Bella P, Elliott PM, Follath F, Gheorghiade M, Hasin Y, Hernborg A, Jaarsma T, Komajda M, Kornowski R, Piepoli M, Prendergast B, Tavazzi L, Vachiery JL, Verheugt FW, Zamorano JL, Zannad F., Eur. J. Heart Fail. 10(10), 2008
PMID: 18826876
Obstructive sleep apnoea and its cardiovascular consequences.
Bradley TD, Floras JS., Lancet 373(9657), 2009
PMID: 19101028
Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial.
Ghio S, Freemantle N, Scelsi L, Serio A, Magrini G, Pasotti M, Shankar A, Cleland JG, Tavazzi L., Eur. J. Heart Fail. 11(5), 2009
PMID: 19287017

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 20846992
PubMed | Europe PMC

Search this title in

Google Scholar